EUVIMEDEUVIMED entdecken
Open Access

Authors’ Reply: Addressing Disparity Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease

Rajiv Agarwal iD

Clinical Journal of the American Society of Nephrology · 2026-06 · 21 (6) · 1111-1111

DOI: 10.2215/cjn.0000001021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 07.04.2026. Verfasst von Rajiv Agarwal. Beteiligte Einrichtung: Division of Nephrology, Richard L. Roudebush VA Medical Center and Indiana University School of Medicine, Indianapolis, Indiana. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bayer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

albuminuriaaldosterone

Autor:innen und Institutionen

  • Division of Nephrology, Richard L. Roudebush VA Medical Center and Indiana University School of Medicine, Indianapolis, Indiana.

ORCID-Profile: Rajiv Agarwal

Förderung

  • Bayer

Zitieren

APA

Agarwal, R. (2026). Authors’ Reply: Addressing Disparity Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology, 21(6), 1111-1111. https://doi.org/10.2215/cjn.0000001021

Vancouver

Agarwal R. Authors’ Reply: Addressing Disparity Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease. Clinical Journal of the American Society of Nephrology. 2026;21(6):1111-1111. doi:10.2215/cjn.0000001021

BibTeX
@article{Agarwal2026,
  author = {Agarwal, Rajiv},
  title = {Authors’ Reply: Addressing Disparity Efficacy of Finerenone–Empagliflozin Combination in Asian Patients with Diabetic Kidney Disease},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {1111--1111},
  doi = {10.2215/cjn.0000001021}
}
Kostenlos starten →